Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
1% 10% 10%
General Information
Revision date
2024-01-01
Product name
Respiratory Syncytial Virus (RSV) vaccine
Product name
Respiratory Syncytial Virus (RSV) vaccine
Identification on the label/Trade name
Not applicable
Product Synonyms
mRNA-1345
Chemical name
Mixture - contains ribonucleotides
CAS No.
57-50-1
1.2.1 Relevant identified uses
Bulk formulated pharmaceutical mixture OR Formulated pharmaceutical product/mixture packaged in final form for patient use; under investigation for the treatment of respiratory syncytial virus (RSV)
Emergency telephone
+1 (617) 714-6500
Icons in SDS
Company Information
company name
Moderna Therapeutics
e-mail address of the competent person responsible for the Safety Data Sheet
sds@modernatx.com
GHS Information
Signal word
Not applicable
Section 2
SECTION 2: Hazards identification
(EC) No 1272/2008 Classification of the substance or mixtur e Not classified
Hazard pictograms
Not applicable
Signal word
Not applicable
Hazard statements
Not applicable
Precautionary statements
Not applicable
2.3 Other hazards
Respiratory Syncytial Virus (RSV) vaccine is an mRNA vaccine against RSV. This mRNA drug product is a lipid nanoparticle (LNP) based delivery system that is non-viral and non-infectious and does not include the possibility of DNA integration. The LNP is comprised of several lipids, including a novel lipid. RSV vaccine has not been tested in humans. The mRNA in the RSV vaccine is not viral or pathogenic and does not require specific biosafety handling recommendations. As an mRNA molecule with a large molecular weight, little to no systemic absorption is expected to occur in a workplace setting. It is also expected to rapidly degrade in the digestive tract following accidental ingestion. Note This mixture does not meet criteria for classification under GHS as implemented by Regulation
2.1 Classification of the substance or mixture
Not classified
